Gyala Therapeutics
PrivateLast Round
Grant
Feb 11, 2026
Total Funding Raised
$9.64M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gyala Therapeutics is a biotechnology company developing next-generation immunotherapies for hematological cancers with high unmet need.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gyala Therapeutics Comparables
Compare Gyala Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OneChain Immunotherapeutics | 86% | |
| iCell Gene Therapeutics | 76% | |
| AvenCell | 73% | |
Gyala Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 11, 2026 | ||||
| Seed | Sep 15, 2025 | ||||
| VC Round | Oct 14, 2024 | ||||
| Seed | May 26, 2020 |
Gyala Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nara Capital | VC Round, Seed |
| Center for Technological Development and Innovation | VC Round, Seed |
| Invivo Partners | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2025
First-in-class therapy targets CD84, showing preclinical efficacy in leukemias.
- Sep 15, 2025
$4M raised from Invivo Partners and Nara Capital.
Gyala Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gyala Therapeutics's valuation, stock price, and market status.